🇬🇧#AZN #отчетность
AstraZeneca Q2 23 Earnings:
- Core EPS $2.15 (est $1.97B)
- Rev $11.42B (est $11.07B)
- Reiterating Guidance For FY 2023 Total Rev And Core EPS